Egypt Artesunate Market Size & Outlook, 2026-2034


Egypt Artesunate Market Insights

  • Based on Reed Intelligence findings, the Egypt Artesunate Market reached USD 5 Million in 2025 and is estimated to attain USD 8.99 Million by 2034.
  • From 2026 to 2034, the Egypt market is expected to grow at a steady CAGR of 6.72%.
  • Within the Formulation category, Injectable Artesunate dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Injectable Artesunate is forecasted to deliver the fastest growth, positioning it as the most lucrative Formulation segment.

Other Key Findings


  • In 2025, Egypt represented 0.96% of the overall global Artesunate Market size.
  • United States is projected to lead the global Artesunate Market size by 2034.
  • Across Middle East and Africa, United Arab Emirates is anticipated to hold the dominant position in market size by 2034.
  • Saudi Arabia is forecasted to expand at the fastest pace in Middle East and Africa, attaining USD 17.03 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 5 Million
Market Size In 2034 USD 8.99 Million
Largest segment Injectable Artesunate
Units Revenue in USD Million
CAGR 6.72% (2026-2034)
Segmnetation Covered
Formulation
  1. Injectable Artesunate
  2. Oral Artesunate
Application
  1. Severe Malaria Treatment
  2. Uncomplicated Malaria Treatment
End-Use
  1. Hospitals
  2. Clinics
  3. Retail Pharmacies
Distribution Channel
  1. Government Supply Programs
  2. Private Sector Distribution
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends